Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions
- PMID: 21558091
- DOI: 10.1258/ebm.2011.011011
Polo-like kinases and DNA damage checkpoint: beyond the traditional mitotic functions
Abstract
Polo-like kinases (Plks) are a family of serine-threonine kinases that play a pivotal role in cell cycle progression and in cellular response to DNA damage. The Plks are highly conserved from yeast to mammals. There are five Plk family members (Plk1-5) in humans, of which Plk1, is the best characterized. The Plk1 isoform is being aggressively pursued as a target for cancer therapy, following observations that this protein is overexpressed in human tumors and is actively involved in malignant transformation. The roles of Plks in mitotic entry, spindle pole functions and cytokinesis are well established and have been the subject of several recent reviews. In this review, we discuss functions of Plks other than their classical roles in mitotic progression. When cells incur DNA damage, they activate checkpoint mechanisms that result in cell cycle arrest and allow time for repair. If the damage is extensive and cannot be repaired, cells will undergo cell death by apoptosis. If the damage is repaired, cells can resume cycling, as part of the process known as checkpoint recovery. If the damage is not repaired or incompletely repaired, cells can override the checkpoint and resume cycling with damaged DNA, a process called checkpoint adaptation. The Plks play a role in all three outcomes and their involvement in these processes will be the subject of this review.
Similar articles
-
Getting in and out of mitosis with Polo-like kinase-1.Oncogene. 2005 Apr 18;24(17):2844-59. doi: 10.1038/sj.onc.1208617. Oncogene. 2005. PMID: 15838519 Review.
-
Polo-like kinases and oncogenesis.Oncogene. 2005 Jan 10;24(2):267-76. doi: 10.1038/sj.onc.1208273. Oncogene. 2005. PMID: 15640842 Review.
-
Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development.Curr Opin Cell Biol. 2008 Dec;20(6):650-60. doi: 10.1016/j.ceb.2008.10.005. Epub 2008 Nov 27. Curr Opin Cell Biol. 2008. PMID: 19000759 Review.
-
Promotion of mitosis by activated protein kinase B after DNA damage involves polo-like kinase 1 and checkpoint protein CHFR.Mol Cancer Res. 2003 Nov;1(13):959-69. Mol Cancer Res. 2003. PMID: 14638868
-
Polo-like kinase-1 in DNA damage response.BMB Rep. 2014 May;47(5):249-55. doi: 10.5483/bmbrep.2014.47.5.061. BMB Rep. 2014. PMID: 24667170 Free PMC article. Review.
Cited by
-
Polo-like kinase 1 inhibits the activity of positive transcription elongation factor of RNA Pol II b (P-TEFb).PLoS One. 2013 Aug 16;8(8):e72289. doi: 10.1371/journal.pone.0072289. eCollection 2013. PLoS One. 2013. PMID: 23977272 Free PMC article.
-
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.Oncotarget. 2015 May 20;6(14):11751-67. doi: 10.18632/oncotarget.3996. Oncotarget. 2015. PMID: 26059434 Free PMC article.
-
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.Int J Mol Sci. 2025 Jan 8;26(2):472. doi: 10.3390/ijms26020472. Int J Mol Sci. 2025. PMID: 39859203 Free PMC article.
-
Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up.Oncol Lett. 2016 Sep;12(3):1667-1674. doi: 10.3892/ol.2016.4890. Epub 2016 Jul 20. Oncol Lett. 2016. PMID: 27602103 Free PMC article.
-
When genome integrity and cell cycle decisions collide: roles of polo kinases in cellular adaptation to DNA damage.Syst Synth Biol. 2014 Sep;8(3):195-203. doi: 10.1007/s11693-014-9151-9. Epub 2014 Jul 27. Syst Synth Biol. 2014. PMID: 25136381 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
